CDKN1A and neoplasm: As discovered by our findings, SNHG1is capable of binding to EZH2, which is a kind of histone methylation modification complex in the nucleus, thus suppressing the target gene’s expression, which includes CDKN1A, an innovative tumor suppressor in CCA.